ALPS Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,203
| Closed | -$556K | – | 981 |
|
|
2024
Q1 | $556K | Sell |
28,203
-13,693
| -33% | -$270K | ﹤0.01% | 580 |
|
|
2023
Q4 | $735K | Sell |
41,896
-29,207
| -41% | -$512K | 0.01% | 547 |
|
|
2023
Q3 | $1.24M | Buy |
71,103
+19,709
| +38% | +$342K | 0.01% | 404 |
|
|
2023
Q2 | $724K | Buy |
+51,394
| New | +$724K | 0.01% | 551 |
|
|
2021
Q4 | – | Sell |
-83,983
| Closed | -$957K | – | 933 |
|
|
2021
Q3 | $957K | Buy |
83,983
+41,412
| +97% | +$472K | 0.01% | 396 |
|
|
2021
Q2 | $593K | Sell |
42,571
-14,659
| -26% | -$204K | 0.01% | 498 |
|
|
2021
Q1 | $1.06M | Buy |
57,230
+603
| +1% | +$11.2K | 0.01% | 392 |
|
|
2020
Q4 | $1M | Buy |
+56,627
| New | +$1M | 0.01% | 390 |
|
|
2019
Q4 | – | Sell |
-38,173
| Closed | -$325K | – | 839 |
|
|
2019
Q3 | $325K | Sell |
38,173
-1,600
| -4% | -$13.6K | ﹤0.01% | 803 |
|
|
2019
Q2 | $539K | Sell |
39,773
-4,795
| -11% | -$65K | ﹤0.01% | 511 |
|
|
2019
Q1 | $805K | Buy |
44,568
+8,115
| +22% | +$147K | 0.01% | 380 |
|
|
2018
Q4 | $1.02M | Buy |
36,453
+8,560
| +31% | +$240K | 0.01% | 299 |
|
|
2018
Q3 | $711K | Buy |
27,893
+6,491
| +30% | +$165K | ﹤0.01% | 465 |
|
|
2018
Q2 | $371K | Buy |
+21,402
| New | +$371K | ﹤0.01% | 813 |
|